shared a link post in group #The Information
Silicon Valley billionaires are pouring billions of dollars into anti-aging startups aimed at dramatically extending human life. #Healthspan Advocates
But while high-profile companies pursue long-term, FDA-approved cellular reprogramming therapies, one small startup, Mitrix Bio, is already offering experimental longevity treatments to paying patients today. #Biohackers Connect
#The Information
theinformation.com/articl..
www.theinformation.com
Longevity Treatments for a 91-Year-Old? A Bold Bet in Silicon Valley’s Immortality Race
In Silicon Valley, some quests for the fountain of youth have most definitely won the backing of tech’s leading names. Sam Altman, OpenAI’s CEO, personally invested $180 million to launch Retro Biosciences, which is working on ways to rejuvenate aging cells. CoinBase’s Brian Armstrong co-founded ...